Evidence map›Paper›PMID 37968278›Full record

ArticleNature communications2023

Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets.

Nicholas L Dooley, Tinashe G Chabikwa, Zuleima Pava, Jessica R Loughland, Julianne Hamelink, Kiana Berry, Dean Andrew, Megan S F Soon, Arya SheelaNair, Kim A Piera and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CumulativeFrontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Malaria: past, present, and future.Signal transduction and targeted therapy · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nicholas L Dooley *QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.ORCID 0000-0002-9692-5627
Tinashe G Chabikwa *QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Zuleima PavaQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Jessica R LoughlandQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Julianne HamelinkQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.ORCID 0000-0001-9480-1914
Kiana BerryQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Dean AndrewQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Megan S F SoonQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Arya SheelaNairQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Kim A PieraMenzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.ORCID 0000-0002-7414-9604
Timothy WilliamInfectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Program, Kota Kinabalu, Sabah, Malaysia.
Bridget E BarberQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.ORCID 0000-0003-1066-7960
Matthew J GriggMenzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.ORCID 0000-0001-9914-8352
Christian R EngwerdaQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
J Alejandro LopezQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.ORCID 0000-0001-9370-1516
Nicholas M AnsteyMenzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Michelle J BoyleQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. michelle.boyle@burnet.edu.au.ORCID 0000-0002-0268-232X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmodium falciparum malaria drives immunoregulatory responses across multiple cell subsets, which protects from immunopathogenesis, but also hampers the development of effective anti-parasitic immunity. Understanding malaria induced tolerogenic responses in specific cell subsets may inform development of strategies to boost protective immunity during drug treatment and vaccination. Here, we analyse the immune landscape with single cell RNA sequencing during P. falciparum malaria. We identify cell type specific responses in sub-clustered major immune cell types. Malaria is associated with an increase in immunosuppressive monocytes, alongside NK and γδ T cells which up-regulate tolerogenic markers. IL-10-producing Tr1 CD4 T cells and IL-10-producing regulatory B cells are also induced. Type I interferon responses are identified across all cell types, suggesting Type I interferon signalling may be linked to induction of immunoregulatory networks during malaria. These findings provide insights into cell-specific and shared immunoregulatory changes during malaria and provide a data resource for further analysis.

Indexed as

Interferon Type IMalariaMalaria, FalciparumHumansInterleukin-10Plasmodium falciparumT-Lymphocyte SubsetsTranscriptomeInterferon Type IInterleukin-10

Identifiers

PMID37968278
PMCPMC10651914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.